Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever
about
Molecular Insights into Crimean-Congo Hemorrhagic Fever VirusCompounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virusA response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response[The "Black Death" : Crimean-Congo hemorrhagic fever].Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome VirusHemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.Crimean-Congo hemorrhagic fever in pregnancy: A systematic review and case series from Russia, Kazakhstan and TurkeyHealth care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009.Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever.Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever.Therapeutic intervention in Crimean-Congo hemorrhagic fever: where are we now?The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever virusesAntiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters.Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses.Clinical Evaluation of Ebola Virus Disease Therapeutics.Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)-Sierra Leone, 2014.Determining Ribavirin's mechanism of action against Lassa virus infection.Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.Treatment-focused Ebola trials, supportive care and future of filovirus care.Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses.Favipiravir (T-705) protects against Nipah virus infection in the hamster model.The Antiviral Drug Arbidol Inhibits Zika Virus.Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses.Extinction of Zika Virus and Usutu Virus by Lethal Mutagenesis Reveals Different Patterns of Sensitivity to Three Mutagenic DrugsExploring Crimean-Congo hemorrhagic fever virus-induced hepatic injury using antibody-mediated type I interferon blockade in miceRibavirin for treating Crimean Congo haemorrhagic feverRecent advances in understanding Crimean-Congo hemorrhagic fever virus
P2860
Q26750548-037E9252-2AF2-4643-826D-A64621DDCBE3Q28084005-6B1E4C66-0D41-428A-9F97-A85BEBED0697Q30196960-07A1B98F-9C46-44CF-B632-E48A5E9072EBQ30949580-B0185BCD-F122-455A-9500-8057B3CA6404Q33433096-7F8BEE87-88BA-4E89-A146-A97409597612Q33439713-3A67AABD-B5ED-4C7A-9487-0ED1D20AF3A4Q33646611-79757C9D-DE59-4F5F-987C-FAA49F58A7DEQ34843676-2FF33393-E687-4F1C-9A84-37915F8816CDQ35952190-8DD4CE2A-9556-4524-A929-3CC64E8CEA65Q36020913-0E660881-312C-4F1C-8FF6-7C92B831BDFFQ36053238-BB113F3A-2636-4C98-A380-590D78A8B9ABQ36146469-004D3E4E-33F7-438E-8495-633FC05C93B7Q36494323-2FCA6AF4-30D8-4BE8-A029-AD6916F48A9CQ37120083-E1144A05-AAF2-43AC-951E-0D8BDE2A4E20Q37538706-7FB46F42-5E84-4C05-9313-9D94DA8072AEQ38617605-A8B438EF-F375-4FC7-BDBD-4F95E2BC22C1Q40044875-8F9E09FA-9E16-4469-AC1A-FFEEDFE556E4Q40082843-F97BC27B-1D48-4A57-A3D2-F6A19428600CQ41718140-C0DF9FFD-8C2F-4632-9542-FD1737D74DEDQ45324172-2184B35F-A384-4CEA-8C4A-91ACF42A0BD2Q47360326-91DCB5B7-9940-4770-90E5-B79E2CEFFA59Q47558474-D4DABCB2-C9A2-4C3F-BDD7-4ED3DC601717Q51782887-12E6DA04-7838-4094-87F4-1E4E3ACF50E1Q53693795-4D8CAD74-D530-447F-9085-F943D14AB195Q54989893-5963875C-44FD-459A-AB28-5C8C1C625397Q55084371-0CF43F0A-0C02-4D44-A91D-BA176167CC8DQ55306089-9F729513-818C-4E70-93EE-1F74522465F4Q56337063-2349D02C-CB04-4D9C-B99A-19FF1E8BB995Q56395356-2FEF53AC-C7BA-404B-92A5-61E728C7240EQ56395446-8403D7A6-2C52-4A02-BE46-AA6D47702A83Q58706047-1A1ABA7B-E49F-4D8A-8AB9-EB4D1867C6E1
P2860
Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Evaluation of antiviral effica ...... rimean-Congo hemorrhagic fever
@ast
Evaluation of antiviral effica ...... rimean-Congo hemorrhagic fever
@en
Evaluation of antiviral effica ...... rimean-Congo hemorrhagic fever
@nl
type
label
Evaluation of antiviral effica ...... rimean-Congo hemorrhagic fever
@ast
Evaluation of antiviral effica ...... rimean-Congo hemorrhagic fever
@en
Evaluation of antiviral effica ...... rimean-Congo hemorrhagic fever
@nl
prefLabel
Evaluation of antiviral effica ...... rimean-Congo hemorrhagic fever
@ast
Evaluation of antiviral effica ...... rimean-Congo hemorrhagic fever
@en
Evaluation of antiviral effica ...... rimean-Congo hemorrhagic fever
@nl
P2093
P2860
P50
P921
P3181
P1476
Evaluation of Antiviral Effica ...... rimean-Congo Hemorrhagic Fever
@en
P2093
Christian Bernreuther
Lisa Oestereich
Maria Lehmann
Melanie Neumann
Petra Emmerich
Stephan Ölschläger
Stephanie Wurr
Toni Rieger
P2860
P3181
P356
10.1371/JOURNAL.PNTD.0002804
P407
P577
2014-05-01T00:00:00Z